Kamar Johnson

Cell and Gene Therapy Commercial Manager
Bio-Techne
Philipp Nold
Kamar Johnson is one of Bio-Techne’s Cell and Gene Therapy (CGT) commercial development managers for Europe. He has extensive experience in working with CGT manufacturers to help fit innovative raw materials into their scale-up, process development and manufacturing of cells and viral vectors. This has involved discussions on improving the raw materials used to provide a more consistent and more “regulatory-friendly” process. This often meant getting rid of serum along with finding xeno-free or even chemically defined products.

Sessions

October 29 2019, 09:30
 - 10:00
Fitting Products To Processes De-Risking Raw Materials To Enhance Scalability